secwatch.observer — SEC 8-K summary
======================================

Issuer:     GILEAD SCIENCES, INC. (GILD)
CIK:        0000882095
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001104659-22-056435
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead shareholders approve 2022 Equity Incentive Plan, elect directors, reject most proposals
--------------------------------------------------------------------------------

- Elected 9 directors; CEO O'Day received 871.8M votes for (87.2%) and 71.4M against.
- Ratified Ernst & Young as auditor for FY2022: 1.02B for, 60.6M against.
- Advisory approval of executive compensation: 875.8M for, 74.4M against, 2.2M abstentions.
- Approved 2022 Equity Incentive Plan authorizing up to 132M shares: 864.6M for, 85.9M against.
- Shareholder proposal for special meeting with 10% threshold passed (52.2% for); independent chair, labor rep, lobbying review, anticompetitive oversight proposals failed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882095/000110465922056435/0001104659-22-056435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882095/000110465922056435/tm2213708d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-056435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer